Cited by 877Immunotherapy and Immune ResponsesT-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers

The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes

Open access

Munn, David H., Sharma, Madhav D., Hou, Deyan, Baban, Babak, Lee, Jeffrey R., Antonia, Scott J., Messina, Jane L., Chandler, Phillip, Koni, Pandelakis A., Mellor, Andrew L.·2004·Journal of Clinical Investigation

DOI 10.1172/jci21583

Open this paper in CoChat — free account Open PDF

Abstract

One mechanism contributing to immunologic unresponsiveness toward tumors may be presentation of tumor antigens by tolerogenic host APCs.We show that mouse tumor-draining LNs (TDLNs) contained a subset of plasmacytoid DCs (pDCs) that constitutively expressed immunosuppressive levels of the enzyme indoleamine 2,3-dioxygenase (IDO).Despite comprising only 0.5% of LN cells, these pDCs in vitro potently suppressed T cell responses to antigens presented by the pDCs themselves and also, in a dominant fashion, suppressed T cell responses to third-party antigens presented by nonsuppressive APCs.Adoptive transfer of DCs from TDLNs into naive hosts created profound local T cell anergy, specifically toward antigens expressed by the transferred DCs.Anergy was prevented by targeted disruption of the IDO gene in the DCs or by administration of the IDO inhibitor drug 1-methyl-D-tryptophan to recipient mice.Within the population of pDCs, the majority of the functional IDO-mediated suppressor activity segregated with a novel subset of pDCs coexpressing the B-lineage marker CD19.We hypothesize that IDO-mediated suppression by pDCs in TDLNs creates a local microenvironment that is potently suppressive of host antitumor T cell responses.Nonstandard abbreviations used: indoleamine 2,3-dioxygenase (IDO); 1-methyl-D-tryptophan (1MT); mixed leukocyte reaction (MLR); plasmacytoid DC (pDC); regulatory T cell (Treg); T cell receptor (TCR); tumor-draining LN (TDLN). Conflict of interest:The authors have declared that no conflict of interest exists.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci21583

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

T cell receptor antagonist peptides induce positive selection.
Hogquist, K., Jameson, S., Heath, W., Howard, J. L., Bevan, M., & Carbone, F. (1994) · Cell · doi:10.1016/0092-8674(94)90169-4 · Cited by 3,252
Tolerogenic Dendritic Cells
Steinman, R. M., Hawiger, D., & Nussenzweig, M. C. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141040 · Cited by 3,162
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.
Dranoff, G., Jaffee, E. M., Lazenby, A., Golumbek, P. T., Levitsky, H., Brose, K., Jackson, V., Hamada, H., Pardoll, D. M., & Mulligan, R. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3539 · Cited by 2,820
Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism
Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I. E., Conway, S. J., Marshall, B., Brown, C. C., & Mellor, A. L. (1998) · Science · doi:10.1126/science.281.5380.1191 · Cited by 2,589
Self-citation
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
Uyttenhove, C., Pilotte, L., Théate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., & Van den Eynde, B. J. (2003) · Nature Medicine · doi:10.1038/nm934 · Cited by 2,305
Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism
Munn, D. H., Shafizadeh, E., Attwood, J. T., Bondarev, I. E., Pashine, A., & Mellor, A. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.9.1363 · Cited by 1,640
Self-citation
Modulation of tryptophan catabolism by regulatory T cells
Fallarino, F., Grohmann, U., Hwang, K. W., Orabona, C., Vacca, C., Bianchi, R., Belladonna, M. L., Fioretti, M. C., Alegre, M., & Puccetti, P. (2003) · Nature Immunology · doi:10.1038/ni1003 · Cited by 1,375
CTLA-4–Ig regulates tryptophan catabolism in vivo
Grohmann, U., Orabona, C., Fallarino, F., Vacca, C., Calcinaro, F., Falorni, A., Candeloro, P., Belladonna, M. L., Bianchi, R., Fioretti, M. C., et al. (2002) · Nature Immunology · doi:10.1038/ni846 · Cited by 1,204
Commitment to the B-lymphoid lineage depends on the transcription factor Pax5
Nutt, S. L., Heavey, B., Rolink, A. G., & Busslinger, M. (1999) · Nature · doi:10.1038/44076 · Cited by 1,179
Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens
Huang, A. Y.-C., Golumbek, P. T., Ahmadzadeh, M., Jaffee, E. M., Pardoll, D. M., & Levitsky, H. I. (1994) · Science · doi:10.1126/science.7513904 · Cited by 1,159

Flagged first, then by citations

Show all 85 references

Research works printed but not linked: 2

Cuenca, 2003, Cancer Res., 63, 9007
Almand, 2000, Clin. Cancer Res., 6, 1755

Sorted by citations

Items 801–877 of 877

Niveles perioperatorios de quinurenina: efectos de la anestesia general VS regional
Sebastián, R. S. (2015) · doi:10.35376/10324/16785
Soluble Mediators of Immune Suppression in the Tumor Microenvironment
Rodrı́guez, P. C., & Ochoa, A. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.17018-3
Der Effekt von immunstimulatorischer DNA und Adenosin auf die Migration und Funktion humaner plasmazytoider dendritischer Zellen
der Abteilung, A., Endres, S., & München, L.-M.-U. (2009)
NIVELES PERIOPERATORIOS DE QUINURENINA: EFECTOS DE LA ANESTESIA GENERAL VS REGIONAL
Doctoral, T. (2015)
Indoleamine 2,3-Dioxygenase in Immune Escape: Regulation and Therapeutic Inhibition
Muller, A. J., & Prendergast, G. C. (2007) · Elsevier eBooks · doi:10.1016/b978-012372551-6/50083-3
Regulation of Anti-tumor T Cell Migration and Function: Contribution of Real-Time Imaging
Loyher, P.-L., Combadière, C., & Boissonnas, A. (2016) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-3-319-42223-7_2
Immune regulation by allergen immunotherapy
Maazi, H., & Shirinbak, S. (2012)
Prognostische Bedeutung der Expression von Indoleamine-2,3- dioxygenase (IDO) in Endothelzellen klarzelliger Nierenzellkarzinome
München, K. D. L.-M.-U., & Hofstetter, A. G. (2008)
Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated-macrophage-like cells Short title: LIF and IL-6 induce TAM-like cells
Hebbar, M., Preisser, P., Anegón, I., Catala, L., Ifrah, N., Descamps, P., Gamelin, E. C., Duluc, D., Delneste, Y., Tan, F., et al. (2007)
Plasma indoleamine 2,3-dioxygenase activity, a potential biomarker for tuberculosis
Adu-Gyamfi, C. G. (2016)
INDOLEAMINE 2, 3-DIOXYGENASE: POTENTIAL IN CANCER IMMUNOTHERAPY
Qureshi, A. M., Nasir, K., Mahroo, A., Zulfiqar, B., & Asghar, K. (2013)
General Properties of Dendritic Cell Populations in Cancer
Daniel, B. J., Jeansonne, D. P., Thibodeaux, S. R., & Curiel, T. J. (2009) · Springer eBooks · doi:10.1007/978-0-387-88611-4_5
Differences between Human and Rodent Plasmacytoid Dendritic Cells May Explain the Pathogenic Disparity of Hantavirus Infection
Lombardi, V. C. (2016)
A possible IDO1- TSP1 role in breast cancer dormancy
Lopes-Bastos, B. (2017) · ORCA Online Research @Cardiff (Cardiff University)
Immune Checkpoint Combinations with Inflammatory Pathway Modulators
DeVito, N. C., Morse, M. A., Hanks, B. A., & Clarke, J. M. (2017) · Current cancer research · doi:10.1007/978-3-319-63757-0_8
Immunomodulation and Vaccination with RHDV VLP
Donaldson, B. (2017) · Otago University Research Archive (University of Otago)
Papel da enzima indoleamina 2,3-dioxigenase (IDO) na imunossupressão induzida pela sepse
Ferreira, R. G. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2017.tde-29032017-150237
Seleção de motivos semelhantes a Papilomavírus, a partir de bibliotecas de phage display, que apresentem potencial aplicação translacional
Sulaiman, L. P. K. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2018.tde-29012018-133017
Sterol regulatory element binding protein is a crucial regulator of natural killer cell metabolism and function
Donnelly, R. P. (2016) · Arrow@dit (Dublin Institute of Technology)
Metabolic reprogramming of tumor-infiltrating myeloid cells conveys protection against pancreatic ductal adenocarcinoma
Sieow, J. L. (2018) · doi:10.32657/10220/47516
Emerging Concepts
Lee, J. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-394385-9.00016-x
Meningeal dendritic cells-astrocytes interactions elevate the kynurenine metabolic pathway to sustain neuropathic painPreprint
Maganin, A. G., Souza, G. R., Fonseca, M. D., Lopes, A. H., Guimarães, R. M., Dagostin, A., Cecilio, N. T., Mendes, A. S., Gomes, F. I., Marques, L. M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.25.428142
Self-citation
The indoleamine 2,3 dioxygenase pathway drives intratumoral B cell maintenancePreprint
Johnson, B. A., Aragaki, A. K., Williams, D. M., Rogers, O. C., Mountain, J., Luo, L., Zhang, W., Xian, L., Feng, M., Chia, L., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.25.456776
differentiation into tumor-associated macrophage-like cells Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte
Gascan, H., Hebbar, M., Jeannin, P., Preisser, L., Anegón, I., Catala, L., Ifrah, N., Descamps, P., Duluc, D., Delneste, Y., et al. (2013)
Cancer Immunotherapy
Sharma, P., Subudhi, S. K., Peggs, K. S., Goswami, S., Gao, J., Quezada, S. A., & Allison, J. P. (2017) · Wiley eBooks · doi:10.1002/9781119000822.hfcm068
Immunology of Cancer
Slingluff, C. L. (2008) · Springer eBooks · doi:10.1007/978-0-387-68113-9_94
Faculty Opinions recommendation of Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen.
Lund, T. (2005) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1021390.279672
Faculty Opinions recommendation of An inherently bifunctional subset of Foxp3+ T helper cells is controlled by the transcription factor eos.
Corr, M. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718011444.793477988
Indoleamine 2,3-dioxygenase
Soliman, H. H. (2017) · Springer eBooks · doi:10.1007/978-1-4419-0717-2_134
Faculty Opinions recommendation of Reprogrammed foxp3(+) regulatory T cells provide essential help to support cross-presentation and CD8(+) T cell priming in naive mice.
Huenig, T. (2011) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.8075957.8464055
GVHD: pDCs providing VIP protection
Shaikh, H., & Beilhack, A. (2022) · Blood · doi:10.1182/blood.2022016451
Supplementary Figure 1 and Methods from Inhibition of Indoleamine 2,3-Dioxygenase in Dendritic Cells by Stereoisomers of 1-Methyl-Tryptophan Correlates with Antitumor Responses
Hou, D., Muller, A. J., Sharma, M. D., DuHadaway, J. B., Banerjee, T., Johnson, M. H., Mellor, A. L., Prendergast, G. C., & Munn, D. H. (2023) · doi:10.1158/0008-5472.22366190
Self-citation
Data from Immunomodulation of Curcumin on Adoptive Therapy with T Cell Functional Imaging in Mice
Chang, Y.-F., Chuang, H., Hsu, C.-H., Liu, R.-S., Gambhir, S. S., & Hwang, J. (2023) · doi:10.1158/1940-6207.c.6544239.v1
Lymphatic System - From Human Anatomy to Clinical Practice
Favero, G., & Facchetti, L. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.111139
Mucosal Exposome and Intestinal Carcinogenesis
Moon, Y. (2024) · Springer eBooks · doi:10.1007/978-3-030-80962-1_370-1
Tumor formation at ileocecal junction associated with interleukin‐1β upregulation in aryl hydrocarbon receptor‐deficient mouse
Ikuta, T., & Kanda, H. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23736
Spatial quantification of cellular metabolism in tissues by metabolic regulome profiling
Glauner, T. A., Truxa, S., Cetin, M., Schlüter, K., Calafato, D., & Hartmann, F. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-822213-3.00006-1
Lymphoid origin of intrinsically activated plasmacytoid dendritic cells in micePreprint
Araujo, A. M., Dekker, J. D., Garrison, K., Su, Z., Rhee, C., Hu, Z., Lee, B., Osorio, D., Lee, J., Iyer, V. R., et al. (2024) · eLife · doi:10.7554/elife.96394.2
Self-citation
Author response: Lymphoid origin of intrinsically activated plasmacytoid dendritic cells in mice
Araujo, A. M., Dekker, J. D., Garrison, K., Su, Z., Rhee, C., Hu, Z., Lee, B., Osorio, D., Lee, J., Iyer, V. R., et al. (2024) · eLife · doi:10.7554/elife.96394.2.sa0
Self-citation
Reviewer #3 (Public Review): Lymphoid origin of intrinsically activated plasmacytoid dendritic cells in mice
(2024) · eLife · doi:10.7554/elife.96394.2.sa1
eLife assessment: Lymphoid origin of intrinsically activated plasmacytoid dendritic cells in mice
Ganguly, D. (2024) · eLife · doi:10.7554/elife.96394.3.sa0
Indoleamine 2,3-Dioxygenase (IDO) and Cancerous Cells
Safdarian, A. R., Farhangnia, P., & Rezaei, N. (2025) · Springer eBooks · doi:10.1007/978-3-032-00759-9_72
Terapias combinadas contra tumores murinos: inmunoterapia y quimioterapia. Relación de la eficacia del tratamiento con el estado inmunológico del portador
Maglioco, A. (2011) · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires)
Dendritic Cells and Cancer: Development, Dysfunction and Therapeutic Targets
Watkins, S. K., & Hurwitz, A. A. (2013) · Springer eBooks · doi:10.1007/978-94-007-6217-6_18
Additional file 1 of Regulatory and effector T cell subsets in tumor-draining lymph nodes of patients with squamous cell carcinoma of head and neck
Norouzian, M., Mehdipour, F., Ashraf, M. J., Khademi, B., & Ghaderi, A. (2022) · Figshare · doi:10.6084/m9.figshare.21557310
Mucosal Exposome and Intestinal Carcinogenesis
문유석 (2025) · Springer eBooks · doi:10.1007/978-3-032-00759-9_370
Division of Labor Between Distinct Human Plasmacytoid Dendritic Cell Subsets Following Viral Activation
Alculumbre, S. G. (2015) · theses.fr (ABES) · doi:10.70675/550d515azc8efz4d48z8e74z0fe1b160bef8
Humanized Mice as Models to study Human Innate Immunity and Immunotherapies
Lopez‐Lastra, S. (2017) · theses.fr (ABES) · doi:10.70675/332ff2f4z793bz4a95zbffcz4be18383be48
Impact de l’enzyme Interleukin-4 induced gene 1 (IL4I1) sur les populations lymphocytaires T régulatrices
Cousin, C. (2014) · theses.fr (ABES) · doi:10.70675/41ccd5b2za7faz4a5fzb045z8c5ebadb4250
Characterization of the in vivo response of naive CD4+ T cells upon tumor neoantigen recognition at different stages of tumor development
Alonso, R. (2016) · theses.fr (ABES) · doi:10.70675/13b19dcbzede0z47d2z8bbez395c6fc8fc4a
Les macrophages au sein du microenvironnement tumoral : étude et modulation des mécanismes moléculaires et cellulaires de la réponse anti-tumorale au cours de carcinoses péritonéales
Prat, M. (2019) · theses.fr (ABES) · doi:10.70675/606044acz15f8z45d8z9566ze0de40cff550
Etude de l'hétérogénéité des cellules dendritiques plasmacytoïdes au cours d'une infection in vivo
Abbas, A. (2019) · theses.fr (ABES) · doi:10.70675/079668e7z9744z463ezbc34zbcebe6034de7
Targeting the metabolic environment to modulate T cell effector function
Matias, M. I. (2019) · theses.fr (ABES) · doi:10.70675/0582ddaaze61dz4707z9cb1zdb8fe1d82653
The Immunomodulatory Effects of Arsenic Trioxide in Autoimmunity and Alloreactivity
Ye, Y. (2019) · theses.fr (ABES) · doi:10.70675/65bfdcabzdb07z4be1z9c7czaa4093c44245
The role of the unfolded protein response in dendritic cells and multiple myeloma cells
Gigan, J. P. (2022) · theses.fr (ABES) · doi:10.70675/e412f7f8zaaafz4caaz8d4czd681169cbf7b
Subversion des sous-types de cellules dendritiques BDCA1+ cDC2s, BDCA2+ pDCs et BDCA3+ cDC1s en contexte de mélanome : implication de l'axe glycan / récepteur lectine de type C
Cuevas, E. S. (2023) · theses.fr (ABES) · doi:10.70675/23ea05c4zd5d6z4b6fz80ddzfb33871b89f9
Dendritic cells as orchestrators in the allergen-specific immunotherapy of allergic diseases
Dou, X., Gu, T., & Xu, Y. P. (2026) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-026-09170-6
Neutrophil metabolic heterogeneity as a novel target in diseases
Zhang, Y., Guo, M., Zhao, D., Liu, H., Ding, X., Yuan, X., Jiang, Y., Feng, D., & Wang, X. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-03112-7
Tryptophan metabolism in colorectal cancer: From mechanistic insights to novel therapeutic strategies
Wang, R., Shen, W., Yang, P., Yang, D., Cao, Y., & Zhou, Y. (2026) · Clinical and Translational Medicine · doi:10.1002/ctm2.70831
Immune remodeling of tumor-draining lymph nodes: mechanistic determinants of checkpoint blockade responsiveness
Jia, C., Li, S., Chen, M., Yang, W., Song, Y., Wang, A., & Liu, B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1963773
Targeting the YAP‐BST2 Axis Overcomes Intrinsic Anti‐PD‐1 Resistance in Metastatic Gastric Cancer
Zhang, W., Wang, S., Wang, M., Yu, R., Yue, J., Shao, L., Zhang, H., Zhu, M., Tian, L., Cheng, S., et al. (2026) · Advanced Science · doi:10.1002/advs.77708
The Endogenous Metabolite Hypochlorite Activates Indoleamine 2,3‐Dioxygenase‐1 for Catalysis: Functional and Mechanistic Implications
Saryazdi, S., & Lanen, S. G. V. (2026) · Angewandte Chemie · doi:10.1002/ange.5275789
The Endogenous Metabolite Hypochlorite Activates Indoleamine 2,3‐Dioxygenase‐1 for Catalysis: Functional and Mechanistic Implications
Saryazdi, S., & Lanen, S. G. V. (2026) · Angewandte Chemie International Edition · doi:10.1002/anie.5275789
BindingDB Entry 50042126: Halicloic acids A and B isolated from the marine sponge Haliclona sp. collected in the Philippines inhibit indoleamine 2,3-dioxygenase.
BindingDB (2013) · UC San Diego · doi:10.7270/q2sq91ps
BindingDB Entry 50043561: TBA
BindingDB (2014) · UC San Diego · doi:10.7270/q2x34zws
BindingDB Entry 50010875: The Structural Basis for Nonsteroidal Anti-Inflammatory Drug Inhibition of Human Dihydrofolate Reductase.
BindingDB (2021) · UC San Diego · doi:10.7270/q2t72n1j
BindingDB Entry 50011687: Discovery and Preclinical Evaluation of BMS-986242, a Potent, Selective Inhibitor of Indoleamine-2,3-dioxygenase 1.
BindingDB (2022) · UC San Diego · doi:10.7270/q2tm7fr5
BindingDB Entry 50013607: Parallel discovery of selective and dual inhibitors of tryptophan dioxygenases IDO1 and TDO2 with a newly-modified enzymatic assay.
BindingDB (2022) · UC San Diego · doi:10.7270/q2df6w0v
BindingDB Entry 50008569: Bifunctional Naphthoquinone Aromatic Amide-Oxime Derivatives Exert Combined Immunotherapeutic and Antitumor Effects through Simultaneous Targeting of Indoleamine-2,3-dioxygenase and Signal Transducer and Activator of Transcription 3.
BindingDB (2021) · UC San Diego · doi:10.7270/q2j969rj
BindingDB Entry 2801: Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors.
BindingDB (2008) · UC San Diego · doi:10.7270/q2vd6wsv
BindingDB Entry 50001561: Recent discovery of indoleamine-2,3-dioxygenase 1 inhibitors targeting cancer immunotherapy.
BindingDB (2020) · UC San Diego · doi:10.7270/q2gx4f22
Dormancy and Metastasis of Melanoma Cells to Lymph Nodes, Lung and Liver
Morris, V. L., Percy, D. B., Lizardo, M. M., Chambers, A. F., & MacDonald, I. C. (2013) · Springer eBooks · doi:10.1007/978-94-007-5958-9_6
Chemotherapeutic Agents in Cancer Treatment and Tryptophan Metabolism
Kesikli, S. A., & Güler, N. (2015) · Molecular and integrative toxicology · doi:10.1007/978-3-319-15630-9_13
Transcriptional Regulation of Dendritic Cells in the Tumor Microenvironment
Jiang, A., Stagliano, K. E., Cuss, S. M., Triplett, A., Fu, C., & Hurwitz, A. A. (2014) · Springer eBooks · doi:10.1007/978-1-4899-8056-4_9
Indoleamine 2,3-Dioxygenase and Tumor-Induced Immune Suppression
Munn, D. H. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9914-6_17
Self-citation
Hematopoietic stem cell-derived dendritic cells express inactive indoleamine 2,3-dioxygenase in vitro
Lindbauer, M. A. (2009) · University of Vienna · doi:10.25365/thesis.7551
Microarray and Proteomic Analysis of Gliomas: Target Strategies
Widegren, B., Persson, O., Fan, X., & Salford, L. G. (2009) · Springer eBooks · doi:10.1007/978-3-642-00475-9_9

Authors: Munn, D. H., Sharma, M. D., Hou, D., Baban, B., Lee, J. R., Antonia, S. J., Messina, J. L., Chandler, P., Koni, P. A., & Mellor, A. L.
Affiliations: Augusta University (US)
University of South Florida (US)
Corresponding author: Munn, David H.
ORCID: Munn, David H.
Sharma, Madhav D.
Baban, Babak
Antonia, Scott J.
Messina, Jane L.
Koni, Pandelakis A.
Mellor, Andrew L.
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2004-07-15
Volume: 114
Issue: 2
Pages: 280-290
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci21583
OpenAlex: W2143565660
Cited by: 852
References: 85
Citations by year: 2026: 13 · 2025: 12 · 2024: 24 · 2023: 15 · 2022: 32 · 2021: 37 · 2020: 34 · 2019: 29 · 2018: 31 · 2017: 40 · 2016: 27 · 2015: 45 · 2014: 38 · 2013: 53 · 2012: 39
FWCI: 19.19
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed (publishedVersion)
Funders: Carlos and Marguerite Mason Trust
National Institutes of Health
National Cancer Institute (R01CA096651, R01 CA103220)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD041187)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords: indoleamine 2,3-dioxygenase, plasmacytoid dendritic cells, tumor-draining lymph nodes, immunosuppression, T cell anergy, tumor antigen presentation, CD19, 1-methyl-D-tryptophan, antitumor immunity, regulatory T cells, mixed lymphocyte reaction
MeSH terms: Animals, Antigen-Presenting Cells, Dendritic Cells, Female, Humans, Immunosuppression Therapy, Lymph Nodes, Lymphocyte Activation, Mice, Inbred Strains, Neoplasms, Random Allocation, T-Lymphocytes, Tryptophan Oxygenase, Survival Rate, Mice, Knockout, Antigens, CD19, Adoptive Transfer, CD11c Antigen, Indoleamine-Pyrrole 2,3,-Dioxygenase, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks